Literature DB >> 12814916

Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.

Wing-Yan Au, Cyrus R Kumana, Maybelle Kou, Raymond Mak, Godfrey C F Chan, Ching-Wan Lam, Yok-Lam Kwong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12814916     DOI： 10.1182/blood-2003-01-0298

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

Review 1.  Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors:  Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

Review 2.  The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy.

Authors:  Lorenzo Falchi; Srdan Verstovsek; Farhad Ravandi-Kashani; Hagop M Kantarjian
Journal:  Cancer       Date:  2015-12-30       Impact factor: 6.860

Review 3.  New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approach.

Authors:  Amer M Zeidan; Steven D Gore
Journal:  Clin Cancer Res       Date:  2014-10-01       Impact factor: 12.531

Review 4.  Arsenic in the treatment of newly diagnosed acute promyelocytic leukemia: current status and future research direction.

Authors:  Jiong Hu
Journal:  Front Med       Date:  2011-03-17       Impact factor: 4.592

5.  Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.

Authors:  Yì-Xiáng J Wáng; Fan Xiao
Journal:  Quant Imaging Med Surg       Date:  2015-06

Review 6.  Arsenic trioxide: insights into its evolution to an anticancer agent.

Authors:  Maneka Hoonjan; Vaibhav Jadhav; Purvi Bhatt
Journal:  J Biol Inorg Chem       Date:  2018-02-02       Impact factor: 3.358

Review 7.  Provocative pearls in diagnosing and treating acute promyelocytic leukemia.

Authors:  Eytan M Stein; Martin S Tallman
Journal:  Oncology (Williston Park)       Date:  2012-07       Impact factor: 2.990

Review 8.  Current first- and second-line treatment options in acute promyelocytic leukemia.

Authors:  Fulvio Massaro; Matteo Molica; Massimo Breccia
Journal:  Int J Hematol Oncol       Date:  2017-02-02

9.  Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis.

Authors:  Wing-Yan Au; Bonnie M Fong; Sidney Tam; Yok-Lam Kwong
Journal:  Ann Hematol       Date:  2012-09-30       Impact factor: 3.673

Review 10.  Acute promyelocytic leukemia current treatment algorithms.

Authors:  Musa Yilmaz; Hagop Kantarjian; Farhad Ravandi
Journal:  Blood Cancer J       Date:  2021-06-30       Impact factor: 11.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.